Jack Arnold
@RheumJArn
Followers
92
Following
95
Statuses
63
Leeds rheumatology registrar. Interested in lupus and connective tissue disease research. Armchair cricket fan and podcast enthusiast
Leeds, England
Joined May 2010
RT @ARD_BMJ: Classifying ANA-positive patients through clinico-biological patterns (including IFN-I expression) may be more efficient than…
0
21
0
RT @Yuz6Yusof: #EULAR2024 OP0145 Can we reclassify people with ANA+ RMD to improve clinical outcomes & stratify for basket trials? Deep mac…
0
11
0
I am very excited to be presenting this work at this year's EULAR! Come and say hi!
📢Introducing #EMEUNETtop10abstractswinner @RheumJArn ! His study represents a collaboration between sites across Europe and the UK. Using advanced deep learning, the authors developed and validated a robust new method to classify ANA-RMDs and predict outcome measures. #EMEUNET
0
0
10
RT @EMEUNET: 💥Get ready to discover the top-rated research from #EMEUNET members at #EULAR2024!💥 Our #EMEUNETtop10abstracts winners are no…
0
2
0
RT @LucyCarter6: Really pleased to share our new paper online now @ARD_BMJ Blood RNA-sequencing across the continuum of ANA-positive autoi…
0
3
0
RT @Yuz6Yusof: #ACR23 Abstr#2335 A step towards equal access to therapy for ANA+ people with arthritis. A cohort study showed: ANA+ (#SLE,…
0
4
0
RT @Yuz6Yusof: A very fruitful meeting with plenty of stimulating discussion #BILAG #lupus Group Meeting in Leeds - celebrating 40th Annive…
0
8
0
RT @Yuz6Yusof: #BSR23 Dr Arnold presented data that ANA+ patients with #arthritis (#lupus, #sjogren, MCTD, UCTD, etc) were homogenous in te…
0
5
0
@Yuz6Yusof @chriswincup @edvital @TheLancetRheum Thanks for the shout out! Always good to add some clarity to a tricky topic.
0
0
1
RT @Yuz6Yusof: Our paper in @TheLancetRheum on Risk of severe #COVID19 outcomes from the use of Rituximab in rheumatic diseases is highligh…
0
8
0
RT @Yuz6Yusof: 📢We analysed all patients with rheumatic diseases on rituximab during #COVID19: Risk-ratio profile still favours RTX if ful…
0
13
0
RT @DrJZed: @SBillingsley123 giving 2 great presentations on #Day5 of #RSNA22 💪👏🎉 @AcademyRad @LeedsRTresearch @LeedsRadiology @andyscarsbr…
0
2
0
RT @RADMagazine: May scientific article: AI in nuclear medicine. Author: Dr Sarah Billingsley, Dr Russell Frood, Professor Andy Scarsbroo…
0
1
0
RT @SBillingsley123: Excellent presentation @RachelJGravell 👏🏻 congratulations on your first #RSNA2022
0
1
0
RT @DrMiniDey: Take a look at the new and updated @RheumatologyUK guidelines on prescribing in pregnancy and breastfeeding, available now f…
0
13
0
RT @Lupusreference: 🆒 In-depth knowledge of the interpretation of #antinuclear antibody (ANA) testing is KEY for the diagnosis of #autoimmu…
0
166
0
RT @MassimoRadin: Great Stuff! I usually discuss with my patients how long should a treatment last :) #SLE #Lupus
0
12
0
RT @TheLancetRheum: NEW RESEARCH—The Lessening the Impact of Fatigue in Inflammatory Rheumatic Disease Trial (LIFT) shows that remotely del…
0
29
0
Off to a meeting in London today, I'm praying the venue has air-con! Scorchio!!!
0
1
7
RT @RheumALN: Don't miss this conversation on how race, ethnicity, age, sexual identity & orientation, and socioeconomic status can affect…
0
12
0